Skip to main content
eWeLL Co.,Ltd. logo

eWeLL Co.,Ltd. — Investor Relations & Filings

Ticker · 5038 ISIN · JP3130160009 T Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 32 across all filing types
Latest filing 2026-04-15 Transaction in Own Shar…
Country JP Japan
Listing T 5038

About eWeLL Co.,Ltd.

https://ewell.co.jp/

eWeLL Co.,Ltd. specializes in developing and providing business support cloud services for the home medical care industry. Its core product is 'iBow,' a SaaS-type electronic medical record (EMR) system designed specifically for visiting nursing stations. The platform aims to drive the digital transformation (DX) of home care operations, enhancing productivity and efficiency. In addition to its EMR system, the company offers Business Process Outsourcing (BPO) services and medical data solutions. eWeLL's strategic vision is to become a comprehensive platform for the home medical care sector, creating new value and addressing key challenges within the field.

Recent filings

Filing Released Lang Actions
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 90% confidence The document is entitled “自己株券買付状況報告書” filed under Article 24-6 of Japan’s Financial Instruments and Exchange Act, detailing the company’s repurchase of its own shares over a reporting period. It is a statutory report of share repurchase activity (treasury stock acquisition), matching the “Transaction in Own Shares” category, code POS.
2026-04-15 Japanese
確認書
Regulatory Filings Classification · 95% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act, Article 24-4-2, Paragraph 1. It serves as an officer certification confirming the accuracy of the company's Annual Securities Report (有価証券報告書). According to the 'Certification Rule', documents that are primarily officer certifications or attestations, even if they reference a specific report, should be classified as Regulatory Filings (RNS) rather than the report itself. FY 14
2026-03-23 Japanese
有価証券報告書－第14期(2025/01/01－2025/12/31)
Annual Report Classification · 100% confidence The document is a 'Yuka Shoken Hokokusho' (Annual Securities Report) for the company 'eWeLL Co., Ltd.' for the fiscal year ending December 31, 2025. This is the primary annual financial and business disclosure document required by the Financial Services Agency of Japan under the Financial Instruments and Exchange Act. It contains detailed financial statements, business descriptions, and management analysis. In the context of the provided filing categories, this corresponds to the '10-K' (Annual Report) classification. FY 2025
2026-03-23 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 100% confidence The document is a '自己株券買付状況報告書' (Report on Status of Acquisition of Treasury Shares) filed under Article 24-6, Paragraph 1 of the Financial Instruments and Exchange Act of Japan. This document specifically details the company's share buyback activity for the period of February 2026. According to the provided filing definitions, reports detailing the company buying back its own shares are classified as 'Transaction in Own Shares' (POS).
2026-03-09 Japanese
確認書
Regulatory Filings
2025-08-14 Japanese
半期報告書－第14期(2025/01/01－2025/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '半期報告書' (Semi-Annual Report) for the company '株式会社ｅＷｅＬＬ' (eWeLL Co., Ltd.) covering the period from January 1, 2025, to June 30, 2025. It contains detailed financial statements, including the balance sheet, income statement, and cash flow statement, as well as management analysis. This fits the definition of an Interim/Quarterly Report (IR). H1 2025
2025-08-14 Japanese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.